The global clinical trial management systems market was valued at US$ 578.6 million in 2016 and is expected to witness a robust CAGR of 13.0% during the forecast period (2017 – 2025).

Clinical Trial Management Systems – Increasing Number of Clinical Trials Leading To the Growth of Clinical Trial Management Systems Market

The Clinical Trial Management System (clinical trial management systems) is an integrated software designed to manage the clinical trial data system used by biotech and pharma companies, it provides customizable functions with advanced technology and tools, which help reduce time and cost during clinical trial by helping to manage large and complex clinical trial data. Also, clinical trial management systems provides various benefits such as easy access to data from various client locations, sharing of information function, data maintenance and security, avoids complexity of administration and helps to manage clinical trials conducted at various locations by providing access to more than one user simultaneously.

According to ClinicalTrials.gov, as of May 2017, 36% clinical trials out of the globe are conducted in United States and 245,188 studies are registered with ClinicalTrials.gov. Furthermore, according to the study conducted by University of Minnesota and University of Michigan by 2018, all the clinical trial conducting company will use OnCore clinical trial management system as OnCore will provide the functional features such as Clinical Research Management, Study Setup, eCRFs, Financials, Visit Tracking & Data Capture, Study Data Management and Revenue Management.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/212

There are two type of clinical trial management systems available and are categorized on the basis of mode of delivery- Cloud based clinical trial management systems and On-premise clinical trial management systems. The Cloud-based/web-based are among the most widely used clinical trial management systems solutions, as it allows for high customization as per requirement, faster turnaround time, and low costs as compared to on-premise clinical trial management systems solutions. Increasing security concerns related to clinical trials data drive companies, especially those focusing on patenting products, also some companies need customization according to their business need, in this cases those companies opt for on-premise clinical trial management systems.

High awareness about the technology for clinical trial management driving the growth of clinical trial management systems market in developed regions

Developed economies such as the U.S., Canada, Germany, Italy, U.K., Australia, Japan and France have well established infrastructure that can support new technologies and being the leading pharmaceutical markets globally, these economies are well backed with funds for improving process efficiencies. As, most major players in the industry are based in North America and Europe they make clinical trial management systems system easily available to clients.

The global clinical trial management systems market was valued at US$ 578.6 million in 2016 and is expected to witness a robust CAGR of 13.0% during the forecast period (2017 – 2025).

Pharmaceuticals manufacturers focusing on achieving first mover advantage is expected to be one of the primary factor for the growth of clinical trial management systems market over the forecast period

The pharmaceuticals sector is highly competitive, with companies vying to achieve first mover advantage, in turn making clinical trials a crucial element. Thus, major players in the market are focusing on integrating clinical trial management systems. The last couple of decades have witnessed robust growth in trade and commerce, with companies across sectors no longer inhibited by physical boundaries. This has enabled companies, including pharmaceuticals manufacturers to tap in to diverse geographical markets in order to increase their consumer base and in turn exponentially increase profits.

The clinical trials helps companies overcome regulatory barriers for drug approval, as they are not restricted to just one market, to conduct trials for rare diseases at diverse locations provides results from humans with different genetic structure, in turn enabling a more complete and effective solution catering to diverse patient population.

Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/212

Contract research organizations (CROs) in emerging economies expected to fuel the growth in clinical trial management systems market

Emerging economies such as India, Brazil, Argentina, and Iran, still lack adequate infrastructure for clinical trials therefore the outsourcing for clinical trials management systems is preferable way to conduct clinical trials in emerging countries. As companies focus on core aspects such as product development and laying major emphasis on reducing costs, this has led to emergence of various CROs especially in Asia Pacific region.

However, companies, especially in unindustrialized economies are still inclined towards use of rudimentary tools such as spreadsheets for database management, mainly due to lack of awareness about clinical trial management systems and also cost concerns is the growth restraining factor in clinical trial management systems market.

Click here to know more about this publish report: https://www.coherentmarketinsights.com/market-insight/clinical-trial-management-system-market-212

Some of the major companies offering clinical trial management systems are Oracle Corporation, Medidata Clinical Cloud, Veeva Systems, Infosys, Bio-Optronics, BioClinica, and MedNet Solutions.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.